Xinhua Chen Selected Research

isobavachin

12/2021

Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinhua Chen Research Topics

Disease

47	Neoplasms (Cancer) 01/2024 - 05/2006
34	Infections 04/2024 - 11/2006
21	Stomach Neoplasms (Stomach Cancer) 02/2024 - 02/2018
16	Inflammation (Inflammations) 02/2024 - 05/2006
14	Diarrhea 05/2024 - 12/2008
13	COVID-19 02/2024 - 09/2020
12	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2013
12	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2011
11	Clostridium Infections 05/2024 - 09/2013
8	Pre-Eclampsia (Preeclampsia) 06/2022 - 06/2005
7	Breast Neoplasms (Breast Cancer) 10/2023 - 02/2016
7	Type 2 Diabetes Mellitus (MODY) 01/2023 - 12/2002
7	Insulin Resistance 01/2023 - 12/2003
7	Carcinoma (Carcinomatosis) 01/2022 - 09/2013
5	Gestational Diabetes (Gestational Diabetes Mellitus) 06/2022 - 08/2005
5	Birth Weight (Birth Weights) 04/2014 - 09/2002
4	Weight Gain 12/2023 - 12/2002
4	Hypoxia (Hypoxemia) 01/2023 - 01/2019
4	Virus Diseases (Viral Diseases) 09/2021 - 10/2013
4	Echinococcosis (Hydatid Cysts) 01/2017 - 02/2010
4	Necrosis 04/2015 - 05/2009
3	Triple Negative Breast Neoplasms 03/2024 - 01/2024
3	Colitis 11/2023 - 12/2008
3	Liver Neoplasms (Liver Cancer) 06/2023 - 08/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 10/2020
3	Viremia 12/2021 - 12/2020
3	Colonic Neoplasms (Colon Cancer) 03/2019 - 03/2008
3	Hyperlipidemias (Hyperlipidemia) 01/2018 - 12/2014
3	Bacterial Infections (Bacterial Infection) 01/2017 - 09/2010
3	Obesity 09/2015 - 12/2002
3	Enteritis 08/2014 - 08/2006
3	Overweight 08/2011 - 12/2002
3	Melanoma (Melanoma, Malignant) 01/2011 - 07/2009
2	Human Influenza (Influenza) 03/2024 - 11/2023
2	Hypertension (High Blood Pressure) 01/2024 - 01/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2024 - 12/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023 - 07/2021
2	Body Weight (Weight, Body) 07/2023 - 06/2022
2	Asymptomatic Infections 07/2022 - 10/2015
2	Hyperglycemia 01/2022 - 09/2010
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 09/2021

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 02/2024 - 08/2014
13	Biomarkers (Surrogate Marker)IBA 07/2023 - 03/2004
10	VaccinesIBA 02/2024 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 12/2023 - 08/2011
8	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 12/2008
8	Nucleic AcidsIBA 03/2023 - 10/2015
7	AntibodiesIBA 11/2023 - 01/2016
6	erucylphosphocholineIBA 01/2022 - 09/2013
5	CarbohydratesIBA 01/2023 - 03/2004
5	Neutralizing AntibodiesIBA 11/2022 - 01/2020
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2002
4	Antiviral Agents (Antivirals)IBA 03/2024 - 03/2019
4	LipidsIBA 02/2024 - 08/2008
4	CalciumIBA 12/2023 - 09/2013
4	Messenger RNA (mRNA)IBA 09/2023 - 10/2020
4	AntioxidantsIBA 07/2023 - 12/2003
4	ChemokinesIBA 03/2023 - 06/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2023 - 10/2014
4	AntigensIBA 01/2023 - 02/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2016
3	Interleukin-6 (Interleukin 6)IBA 02/2024 - 12/2016
3	B7-H1 AntigenIBA 12/2023 - 01/2022
3	EnzymesIBA 07/2023 - 08/2005
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2021
3	ginsenoside Rg3IBA 10/2022 - 01/2020
3	Polysaccharides (Glycans)IBA 07/2022 - 07/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2013
3	hydroxide ionIBA 04/2014 - 01/2012
2	apatinibIBA 03/2024 - 01/2024
2	Antimicrobial PeptidesIBA 02/2024 - 09/2013
2	CathelicidinsIBA 02/2024 - 09/2013
2	IonsIBA 12/2023 - 07/2009
2	MicroRNAs (MicroRNA)IBA 09/2023 - 10/2020
2	Immune Checkpoint InhibitorsIBA 09/2023 - 01/2022
2	Long Noncoding RNAIBA 06/2023 - 10/2020
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2023 - 01/2023
2	InterleukinsIBA 03/2023 - 01/2020
2	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 01/2020
2	AntitoxinsIBA 01/2023 - 01/2016
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 12/2022 - 07/2022
2	GinsenosidesIBA 10/2022 - 08/2018
2	FlavonoidsIBA 07/2022 - 12/2014
2	AdiponectinIBA 06/2022 - 12/2015
2	2019-nCoV Vaccine mRNA-1273IBA 01/2022 - 08/2021
2	MetalsIBA 12/2021 - 02/2016

Therapy/Procedure

33	Therapeutics 12/2023 - 05/2006
16	Drug Therapy (Chemotherapy) 01/2024 - 01/2011
11	Gastrectomy 01/2024 - 02/2018
4	Immunotherapy 12/2023 - 01/2020
4	Aftercare (After-Treatment) 04/2021 - 12/2008
4	Electrodes (Electrode) 07/2017 - 12/2009
3	Electroacupuncture 01/2023 - 01/2021
3	Length of Stay 01/2021 - 08/2018
3	Punctures 01/2020 - 08/2015
3	Liver Transplantation 06/2018 - 10/2016
2	Hyperthermic Intraperitoneal Chemotherapy 01/2024 - 05/2018
2	Lymph Node Excision (Lymph Node Dissection) 01/2024 - 02/2018
2	Acupuncture Therapy 12/2022 - 05/2021
2	Catheter Ablation 01/2022 - 09/2021